Regulatory Consultant (19-00729) – NJ – East Hanover

Regulatory consultant works under minimal supervision to support the development of digital and other innovative technologies, as stand alone or in combination with *** products. This role supports Global Program Regulatory Directors (GPRDs) and Digital Development teams in operationally implementing the global regulatory strategy for the development of Client technologies and approaches to clinical development, applying expertise in drug development and medical device regulations. Technology may include sensors and Client endpoints, digital tools for drug development (eSource, eICF, ePRO etc.), software as a medical device (SaMD) and others. The Regulatory Consultant may participate in strategy development for health authority meetings, the development of briefing materials, assessment of tools (e.g. SaMD).
Major Accountabilities
Responsible for implementing regulatory strategy and managing operational activities for assigned technology/digital projects or teams (as assigned).
Provides input into global regulatory strategy and contributes to Regulatory Functional Plans (RFPs) and Seed Documents, or their equivalents, which outline the global strategic plan for assigned projects.
Develops knowledge in evolving regulatory requirements for digital and other innovative technology programs, and medical device and drug development/maintenance
Understands commercial drivers, including patent and exclusivity matters, patient engagement and advertising and promotional regulations to fulfil business objectives.
Participates in digital support meetings, including SaMD assessment, Block Chain RA Digital Network, and CPO digital/device meetings as assigned.
Supports regions (as assigned) to align on regulatory strategy in order to fulfil business objectives
Supports HA interactions, including the preparation and finalization of briefing books, rehearsals for HA meetings and responses to HA questions.
Supports GPRD-Innovation / DU GPRD on global submissions (including CTAs, INDs, 510Ks, PMA, IDEs, NDAs, dossiers and device clearance planning processes for assigned projects).
Interfaces with external organizations, such as CTTI, PhRMA, EFPIA subcommittees TransCelerate and via initiatives including Innovative Medicines Initiative (IMI) (as assigned).
Supports DU-GPRD-Innovation in developing Development Core Data Sheet (DCDS) and Core Data Sheet (CDS) for combination products and Instructions for Use for digital devices, consistent with development data and commercial objectives of the TPP.
Develops the Development Core Data Sheet (DCDS) and Core Data Sheet (CDS) with DU RA GPT representative for combination products and Instructions for Use for digital devices, consistent with development data and commercial objectives of the TPP.
Ensures compliance with global regulatory requirements and adherence to regulatory internal policies and processes, and keeps records of all major HA interactions in the validated document management system.
Supports digital technologies and digital device evaluations in line with established governance procedures.

Strong knowledge of regulatory development, submission and approval processes in 1 or more major regions for drugs and medical devices, including digital devices (preferred).
Experience in a global/matrix environment or cross-functional teams in the pharmaceutical industry.
Experience in HA negotiations.
4-6 years involvement in regulatory, drug/biologic development and/or medical device/pharmaceutical combination products spanning activities in Phases I-IV
Strong interpersonal, communication, negotiation, leadership and problem solving skills.
Source: Job Diva – Job Listing

Leave a Reply

Your email address will not be published. Required fields are marked *